tiprankstipranks
Trending News
More News >
Evolutionary Genomics (FNAM)
:FNAM
US Market
Advertisement

Evolutionary Genomics (FNAM) Cash flow

Compare
1 Followers

Evolutionary Genomics Cash Flow

FNAM's free cash flow for Q4 2022 was $-188.48K. For the 2022 fiscal year, FNAM's free cash flow was decreased by $942.19K and operating cash flow was $-188.48K. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -640.95K$ -1.58M$ -2.30M$ -625.98K$ -748.84K
Investing Cash Flow
$ 0.00$ 0.00$ 147.61K$ 0.00$ 0.00
Financing Cash Flow
$ 1.00M$ 1.58M$ 2.32M$ 540.01K$ -242.37K
End Cash Position
$ 577.07K$ 214.01K$ 215.84K$ 45.44K$ 131.41K
Free Cash Flow
$ -640.95K$ -1.58M$ -2.30M$ -625.98K$ -748.84K
Currency in USD

Evolutionary Genomics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis